roche holding ag fda says rocephin can be risky for babies reuters u s regulators warned doctors of new risks to newborn babies including death associated with combining an antibiotic made by swiss drug maker roche holding ag with certain other treatments the food and drug administration said that the injection called rocephin or ceftriaxone sodium shouldnt be combined with calcium or products that contain calcium following reports of fatal reactions in newborns the fda reported the warning on its web site a spokesman for roche usa couldnt be reached 
